Evidence map›Paper›PMID 26810075›Full record

ReviewMolecules and cells2016

Distribution and Features of the Six Classes of Peroxiredoxins.

Leslie B Poole, Kimberly J Nelson

Open access · diamondAbstract readReview
In one paragraph

Review in Molecules and cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Identification ofAntioxidants (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Glutathione-Related Enzymes and Proteins: A Review.Molecules (Basel, Switzerland) · 2023
    Review
  11. mBio · 2022
    Article
  12. Article
  13. Article
  14. Structural New Data for Mitochondrial Peroxiredoxin FromFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Oxidants in Physiological Processes.Handbook of experimental pharmacology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Leslie B PooleDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Kimberly J NelsonDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA ; Department of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA.
Wake Forest University · US

Funding

Mechanistic Studies of Alkyl Hydroperoxide Reductase and Related Redox SystemsR01GM050389 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI POOLE, LESLIE B · 1994 to 2013
$4.8M
NIGMS NIH HHS R01 GM050389
6 · The paper itself

Abstract

Peroxiredoxins are cysteine-dependent peroxide reductases that group into 6 different, structurally discernable classes. In 2011, our research team reported the application of a bioinformatic approach called active site profiling to extract active site-proximal sequence segments from the 29 distinct, structurally-characterized peroxiredoxins available at the time. These extracted sequences were then used to create unique profiles for the six groups which were subsequently used to search GenBank(nr), allowing identification of ∼3500 peroxiredoxin sequences and their respective subgroups. Summarized in this minireview are the features and phylogenetic distributions of each of these peroxiredoxin subgroups; an example is also provided illustrating the use of the web accessible, searchable database known as PREX to identify subfamily-specific peroxiredoxin sequences for the organism Vitis vinifera (grape).

Indexed as

Databases, ProteinPeroxiredoxinsPhylogenyPlant ProteinsSequence Analysis, ProteinUser-Computer InterfaceVitisPeroxiredoxinsPlant Proteinsactive site profilingbioinformaticsdisulfide reductaseperoxide reductasethiol peroxidase

Identifiers

PMID26810075
PMCPMC4749874
OpenAlexW2410607597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.